<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22927911</PMID><DateCompleted><Year>2013</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>8</Issue><PubDate><Year>2012</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Dengue virus serotype 2 blocks extracellular signal-regulated kinase and nuclear factor-&#x3ba;B activation to downregulate cytokine production.</ArticleTitle><Pagination><StartPage>e41635</StartPage><MedlinePgn>e41635</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e41635</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0041635</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Dengue virus (DENV) infection is the most common mosquito-borne viral disease threatening human health around the world. Type I interferon (IFN) and cytokine production are crucial in the innate immune system. We previously reported that DENV serotype 2 (DENV-2) induced low levels of interferon regulatory factor 3 and NF-&#x3ba;B activation, thus leading to reduced production of IFN-&#x3b2; in the early phase of infection. Here, we determined whether DENV infection not only hampers type I IFN activation but also cytokine production triggered by Toll-like receptor (TLR) signaling.</AbstractText><AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">We used quantitative RT-PCR and found that only low levels of IFN-&#x3b2; and inflammatory cytokines such as interleukin 10 (IL-10), IL-12 and tumor necrosis factor &#x3b1; (TNF&#x3b1;) mRNA were detected in DENV-2-infected bone-marrow-derived dendritic cells. Furthermore, DENV-2 infection repressed cytokine production triggered by TLR signaling. To elucidate the molecular mechanisms underlying this suppression event, we measured NF-&#x3ba;B activation by p65 nuclear translocation and luciferase reporter assay and found that NF-&#x3ba;B activation triggered by TLR ligands was blocked by DENV-2 infection. As well, extracellular signal-regulated kinase (ERK) activity was suppressed by DENV-2 infection.</AbstractText><AbstractText Label="CONCLUSIONS/SIGNIFICANCE" NlmCategory="CONCLUSIONS">To downregulate the host innate immunity, DENV-2 by itself is a weak inducer of type I IFN and cytokines, furthermore DENV-2 can also block the TLR-triggered ERK-NF-&#x3ba;B activation and cytokine production.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Tsung-Hsien</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. changth@vghks.gov.tw</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Siang-Ru</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Chia-Yi</ForeName><Initials>CY</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>You-Sheng</ForeName><Initials>YS</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yao-Shen</ForeName><Initials>YS</Initials></Author><Author ValidYN="Y"><LastName>Kubota</LastName><ForeName>Toru</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Matsuoka</LastName><ForeName>Mayumi</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yi-Ling</ForeName><Initials>YL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051193">Toll-Like Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D019950">Mitogen-Activated Protein Kinase 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D048052">Mitogen-Activated Protein Kinase 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001854" MajorTopicYN="N">Bone Marrow Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="Y">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019950" MajorTopicYN="N">Mitogen-Activated Protein Kinase 1</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048052" MajorTopicYN="N">Mitogen-Activated Protein Kinase 3</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051193" MajorTopicYN="N">Toll-Like Receptors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22927911</ArticleId><ArticleId IdType="pmc">PMC3425550</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0041635</ArticleId><ArticleId IdType="pii">PONE-D-12-10163</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Martina BE, Koraka P, Osterhaus AD (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22: 564&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772360</ArticleId><ArticleId IdType="pubmed">19822889</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman AL (2004) Dengue: defining protective versus pathologic immunity. J Clin Invest 113: 946&#x2013;951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC379334</ArticleId><ArticleId IdType="pubmed">15057297</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, et al. (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8: S7&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4333201</ArticleId><ArticleId IdType="pubmed">21079655</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall WC, Crowell TP, Watts DM, Barros VL, Kruger H, et al. (1991) Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis. Am J Trop Med Hyg 45: 408&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">1951849</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessie K, Fong MY, Devi S, Lam SK, Wong KT (2004) Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 189: 1411&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pubmed">15073678</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, et al. (2000) Human skin Langerhans cells are targets of dengue virus infection. Nat Med 6: 816&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pubmed">10888933</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyle JL, Beatty PR, Harris E (2007) Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J Infect Dis 195: 1808&#x2013;1817.</Citation><ArticleIdList><ArticleId IdType="pubmed">17492597</ArticleId></ArticleIdList></Reference><Reference><Citation>Versteeg GA, Garcia-Sastre A (2010) Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 13: 508&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2920345</ArticleId><ArticleId IdType="pubmed">20538505</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XD, Sun L, Seth RB, Pineda G, Chen ZJ (2005) Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 102: 17717&#x2013;17722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1308909</ArticleId><ArticleId IdType="pubmed">16301520</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M, et al. (2005) Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79: 8004&#x2013;8013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1143737</ArticleId><ArticleId IdType="pubmed">15956546</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A (2003) Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 100: 14333&#x2013;14338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC283592</ArticleId><ArticleId IdType="pubmed">14612562</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang TH, Liao CL, Lin YL (2006) Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes Infect 8: 157&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">16182584</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Madoz JR, Belicha-Villanueva A, Bernal-Rubio D, Ashour J, Ayllon J, et al. (2010) Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol 84: 9760&#x2013;9774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2937777</ArticleId><ArticleId IdType="pubmed">20660196</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Madoz JR, Bernal-Rubio D, Kaminski D, Boyd K, Fernandez-Sesma A (2010) Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol 84: 4845&#x2013;4850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2863727</ArticleId><ArticleId IdType="pubmed">20164230</ArticleId></ArticleIdList></Reference><Reference><Citation>Sariol CA, Munoz-Jordan JL, Abel K, Rosado LC, Pantoja P, et al. (2007) Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1. Clin Vaccine Immunol 14: 756&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1951081</ArticleId><ArticleId IdType="pubmed">17428947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21: 317&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2721684</ArticleId><ArticleId IdType="pubmed">19246554</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">20404851</ArticleId></ArticleIdList></Reference><Reference><Citation>Tato CM, Hunter CA (2002) Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection. Infect Immun 70: 3311&#x2013;3317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC128040</ArticleId><ArticleId IdType="pubmed">12065467</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Vliet K, Mohamed MR, Zhang L, Villa NY, Werden SJ, et al. (2009) Poxvirus proteomics and virus-host protein interactions. Microbiol Mol Biol Rev 73: 730&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2786582</ArticleId><ArticleId IdType="pubmed">19946139</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SH, Park KJ, Ahn BY, Jung G, Lai MM, et al. (2006) Hepatitis C virus nonstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular IkappaB kinase. Mol Cell Biol 26: 3048&#x2013;3059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1446972</ArticleId><ArticleId IdType="pubmed">16581780</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Gao J, Zheng H, Li B, Kong L, et al. (2007) The membrane protein of SARS-CoV suppresses NF-kappaB activation. J Med Virol 79: 1431&#x2013;1439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166727</ArticleId><ArticleId IdType="pubmed">17705188</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuhmann KM, Pfaller CK, Conzelmann KK (2011) The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity. J Virol 85: 3162&#x2013;3171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3067892</ArticleId><ArticleId IdType="pubmed">21270162</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Li H, Zhang Z, Meng J, Mao D, et al. (2011) Enterovirus 71 2C Protein Inhibits TNF-{alpha}-Mediated Activation of NF-{kappa}B by Suppressing I{kappa}B Kinase {beta} Phosphorylation. J Immunol</Citation><ArticleIdList><ArticleId IdType="pubmed">21810613</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, Liao CL, Chen LK, Yeh CT, Liu CI, et al. (1998) Study of Dengue virus infection in SCID mice engrafted with human K562 cells. J Virol 72: 9729&#x2013;9737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110483</ArticleId><ArticleId IdType="pubmed">9811707</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang TH, Kubota T, Matsuoka M, Jones S, Bradfute SB, et al. (2009) Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathog 5: e1000493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2696038</ArticleId><ArticleId IdType="pubmed">19557165</ArticleId></ArticleIdList></Reference><Reference><Citation>Tailor P, Tamura T, Kong HJ, Kubota T, Kubota M, et al. (2007) The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 27: 228&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768351</ArticleId><ArticleId IdType="pubmed">17702615</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Altamirano MM, Sanchez-Garcia FJ, Legorreta-Herrera M, Aguilar-Carmona I (2007) Susceptibility of mouse macrophage J774 to dengue virus infection. Intervirology 50: 237&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">17356302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13: 816&#x2013;825.</Citation><ArticleIdList><ArticleId IdType="pubmed">16410796</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenardo MJ, Fan CM, Maniatis T, Baltimore D (1989) The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57: 287&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">2495183</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z, Wu S, Li Y, He L, Wu M, et al. (2011) Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-beta in cultured hepatoma cells. PLoS One 6: e23346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3150425</ArticleId><ArticleId IdType="pubmed">21829730</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanteux H, Guisset AC, Pilette C, Sibille Y (2007) LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms. Respir Res 8: 71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2080632</ArticleId><ArticleId IdType="pubmed">17916230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas M, Zhang X, Prasanna V, Mosser DM (2005) ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus. J Immunol 175: 469&#x2013;477.</Citation><ArticleIdList><ArticleId IdType="pubmed">15972681</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Ma Y, Barrett JW, Gao X, Loh J, et al. (2004) Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier. Nat Immunol 5: 1266&#x2013;1274.</Citation><ArticleIdList><ArticleId IdType="pubmed">15502830</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman AL (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11: 532&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pubmed">21760609</ArticleId></ArticleIdList></Reference><Reference><Citation>Chareonsirisuthigul T, Kalayanarooj S, Ubol S (2007) Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol 88: 365&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">17251552</ArticleId></ArticleIdList></Reference><Reference><Citation>Ubol S, Phuklia W, Kalayanarooj S, Modhiran N (2010) Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J Infect Dis 201: 923&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">20158392</ArticleId></ArticleIdList></Reference><Reference><Citation>Modhiran N, Kalayanarooj S, Ubol S (2010) Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse. PLoS Negl Trop Dis 4: e924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3006139</ArticleId><ArticleId IdType="pubmed">21200427</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pubmed">11244051</ArticleId></ArticleIdList></Reference><Reference><Citation>Trandem K, Zhao J, Fleming E, Perlman S (2011) Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis. J Immunol 186: 3642&#x2013;3652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3063297</ArticleId><ArticleId IdType="pubmed">21317392</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyktor JC, Turner J (2011) Interleukin-10 and Immunity against Prokaryotic and Eukaryotic Intracellular Pathogens. Infect Immun 79: 2964&#x2013;2973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3147550</ArticleId><ArticleId IdType="pubmed">21576331</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, et al. (2006) Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg 74: 142&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">16407359</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen RF, Liu JW, Yeh WT, Wang L, Chang JC, et al. (2005) Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 44: 43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">15780577</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Town T, Qian F, Wang P, Kamanaka M, et al. (2009) IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog 5: e1000610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2749443</ArticleId><ArticleId IdType="pubmed">19816558</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan WH, Helt AM, Maranon C, Barbaroux JB, Hosmalin A, et al. (2005) Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection. J Virol 79: 7291&#x2013;7299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1143643</ArticleId><ArticleId IdType="pubmed">15919883</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonnak K, Slike BM, Burgess TH, Mason RM, Wu SJ, et al. (2008) Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J Virol 82: 3939&#x2013;3951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2292981</ArticleId><ArticleId IdType="pubmed">18272578</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J, Wang H, Hajishengallis GN, Martin M (2011) TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J Dent Res 90: 417&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3075579</ArticleId><ArticleId IdType="pubmed">20940366</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes PJ, Karin M (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066&#x2013;1071.</Citation><ArticleIdList><ArticleId IdType="pubmed">9091804</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter AB, Monick MM, Hunninghake GW (1999) Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 20: 751&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pubmed">10101008</ArticleId></ArticleIdList></Reference><Reference><Citation>Guma M, Stepniak D, Shaked H, Spehlmann ME, Shenouda S, et al. (2011) Constitutive intestinal NF-{kappa}B does not trigger destructive inflammation unless accompanied by MAPK activation. J Exp Med 208: 1889&#x2013;1900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3171091</ArticleId><ArticleId IdType="pubmed">21825016</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J, Pan W, Wang P (2011) ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro. Virol J 8: 468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3215395</ArticleId><ArticleId IdType="pubmed">21992229</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, et al. (2008) CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453: 672&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">18496526</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin RJ, Yu HP, Chang BL, Tang WC, Liao CL, et al. (2009) Distinct antiviral roles for human 2&#x2032;,5&#x2032;-oligoadenylate synthetase family members against dengue virus infection. J Immunol 183: 8035&#x2013;8043.</Citation><ArticleIdList><ArticleId IdType="pubmed">19923450</ArticleId></ArticleIdList></Reference><Reference><Citation>Su HL, Lin YL, Yu HP, Tsao CH, Chen LK, et al. (2001) The effect of human bcl-2 and bcl-X genes on dengue virus-induced apoptosis in cultured cells. Virology 282: 141&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">11259197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wati S, Li P, Burrell CJ, Carr JM (2007) Dengue virus (DV) replication in monocyte-derived macrophages is not affected by tumor necrosis factor alpha (TNF-alpha), and DV infection induces altered responsiveness to TNF-alpha stimulation. J Virol 81: 10161&#x2013;10171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2045434</ArticleId><ArticleId IdType="pubmed">17626094</ArticleId></ArticleIdList></Reference><Reference><Citation>Chase AJ, Medina FA, Munoz-Jordan JL (2011) Impairment of CD4+ T cell polarization by dengue virus-infected dendritic cells. J Infect Dis 203: 1763&#x2013;1774.</Citation><ArticleIdList><ArticleId IdType="pubmed">21606535</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>